1 not yet recruiting. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Not yet recruiting 1 |
Follow Open Source Pharma Foundation: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Trial of 2 Disease-Modifying Drugs (Metformin and N-acetylcysteine ) to Promote TB Lung Function Recovery Metformin, N-Acetylcysteine (NAC) Treatment, Standard TB treatment - Tuberculosis | Phase 3 | Not yet recruiting | Open Source Pharma Foundation | 1104 | 2026-01-01 | 2025-08-22 |
Recurrence (1) · Tuberculosis (1)
Acetylcysteine (1) · Metformin (1) · Therapeutics (1)
PMID 34849651, PMID 38019456, PMID 38850838, PMID 39189858, PMID 39756697